AHRQ to identify Medicaid meaningful use barriers

The Agency for Healthcare Research and Quality (AHRQ) intends to identify barriers for Medicaid participants to meet meaningful use EHR requirements to qualify for incentive payments.

In the Jan. 18 Federal Register, AHRQ released a notice to request that the Office of Management and Budget (OMB) approve the proposed information collection project titled “Barriers to Meaningful Use in Medicaid.”

The information will be used to develop recommendations to overcoming barriers to meaningful use of EHRs for Medicaid providers, including but not limited to technical assistance that could be made available to Medicaid providers, according to AHRQ.

“Furthermore, the data gathered through this research will inform the meaningful use objectives being developed by Centers for Medicare & Medicaid Services for Stages 2 and 3 of the EHR Incentive Program,” the agency stated.

Comments on this notice must be received by March 21.

Around the web

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.